After chemotherapy and prior to surgery, 36.4% and 27.3% of patients had persistent elevation of traditional serum tumour markers in the teratoma (two LDH, one HCG, one AFP/LDH) and NFVT group (one LDH, one AFP, one HCG), respectively. The gene discussed is AFP; the disease is teratoma.